Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The direct and indirect cost burden of acute coronary syndrome.

Johnston SS, Curkendall S, Makenbaeva D, Mozaffari E, Goetzel R, Burton W, Maclean R.

J Occup Environ Med. 2011 Jan;53(1):2-7. doi: 10.1097/JOM.0b013e31820290f4.

PMID:
21187788
2.

The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costs.

Page RL 2nd, Ghushchyan V, Gifford B, Read RA, Raut M, Crivera C, Naim AB, Damaraju CV, Nair KV.

J Occup Environ Med. 2013 Jul;55(7):761-7. doi: 10.1097/JOM.0b013e318297323a.

PMID:
23787565
3.

Costs of payment in Thai acute coronary syndrome patients.

Moleerergpoom W, Kanjanavanit R, Jintapakorn W, Sritara P.

J Med Assoc Thai. 2007 Oct;90 Suppl 1:21-31.

PMID:
18431883
4.

Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation.

Roggeri DP, Roggeri A, Rossi E, Cinconze E, De Rosa M, Maggioni AP; ARNO Cardiovascular Observatory..

Eur J Prev Cardiol. 2014 Sep;21(9):1090-6. doi: 10.1177/2047487313483608. Epub 2013 Mar 20.

PMID:
23515447
5.

Economic burden of illness of acute coronary syndromes: medical and productivity costs.

Zhao Z, Winget M.

BMC Health Serv Res. 2011 Feb 14;11:35. doi: 10.1186/1472-6963-11-35.

6.

Cost of care for new versus recurrent acute coronary syndrome patients.

Shetty S, Halpern R, McCollam PL.

J Med Econ. 2008;11(1):81-99. doi: 10.3111/13696990801913968.

PMID:
19450112
7.

Economic consequences of ACS-related rehospitalizations in the US.

Berenson K, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J.

Curr Med Res Opin. 2010 Feb;26(2):329-36. doi: 10.1185/03007990903479331.

PMID:
19968457
8.

Economic burden of acute coronary syndrome in South Korea: a national survey.

Kim J, Lee E, Lee T, Sohn A.

BMC Cardiovasc Disord. 2013 Aug 8;13:55. doi: 10.1186/1471-2261-13-55.

9.

Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events.

Korsnes JS, Davis KL, Ariely R, Bell CF, Mitra D.

J Manag Care Spec Pharm. 2015 Jun;21(6):443-50.

10.

Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.

Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET.

Pharmacoeconomics. 2010;28(5):395-409. doi: 10.2165/11531040-000000000-00000.

PMID:
20402541
11.

[Morbi-mortality and use of recourses after acute coronary syndrome in a Spanish population].

Sicras-Mainar A, Fernández de Bobadilla J, Navarro-Artieda R, Martín I, Varela-Moreno C.

Rev Clin Esp. 2011 Dec;211(11):560-71. doi: 10.1016/j.rce.2011.07.007. Epub 2011 Nov 14. Spanish.

PMID:
22088667
12.

Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel.

Chastek B, Riedel AA, Wygant G, Hauch O.

Curr Med Res Opin. 2009 Dec;25(12):2845-52. doi: 10.1185/03007990903333017.

PMID:
19831706
13.

Resource consumption and healthcare costs of acute coronary syndrome: a retrospective observational administrative database analysis.

Roggeri A, Gnavi R, Dalmasso M, Rusciani R, Giammaria M, Anselmino M, Roggeri DP.

Crit Pathw Cardiol. 2013 Dec;12(4):204-9. doi: 10.1097/HPC.0b013e3182a78c06.

PMID:
24240551
14.

One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database.

Menzin J, Wygant G, Hauch O, Jackel J, Friedman M.

Curr Med Res Opin. 2008 Feb;24(2):461-8. doi: 10.1185/030079908X261096 .

PMID:
18194592
15.

Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis.

Meadows ES, Bae JP, Zagar A, Sugihara T, Ramaswamy K, McCracken R, Heiselman D.

BMC Res Notes. 2012 Jul 2;5:342. doi: 10.1186/1756-0500-5-342.

16.
17.

Coronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruption.

Johnston SS, Bell K, Gdovin J, Jing Y, Graham J.

Hosp Pract (1995). 2012 Feb;40(1):15-23. doi: 10.3810/hp.2012.02.944.

PMID:
22406879
18.

Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.

Arnold SV, Morrow DA, Lei Y, Cohen DJ, Mahoney EM, Braunwald E, Chan PS.

Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):344-53. doi: 10.1161/CIRCOUTCOMES.108.829523. Epub 2009 Jun 2.

19.

Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.

Doshi JA, Cai Q, Buono JL, Spalding WM, Sarocco P, Tan H, Stephenson JJ, Carson RT.

J Manag Care Spec Pharm. 2014 Apr;20(4):382-90.

20.

Supplemental Content

Support Center